 |
macitentan |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic thromboembolic pulmonary hypertension (CTEPH) |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Actelion Clinical Research, Inc.;1820 Chapel Avenue West, Suite 300;Cherry Hill, New Jersey, 08002 |
